Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


USANA lowers guidance

This article was originally published in The Tan Sheet

Executive Summary

The direct-seller of nutritional, personal care and weight management products projects 2009 net sales of $390 million to $400 million, a 7 to 9 percent decrease from its 2008 revenues. USANA Health Sciences in February projected a 6 to 8 percent reduction in net sales for the year, accounting for foreign exchange losses. In its 2009 first quarter, the Salt Lake City-based company said April 28 it saw global net sales fall 4.2 percent to $97.3 million and North American revenues dropped 10.2 percent to $55.9 million. Though the firm pinned its declines largely on the negative impact of currency changes, net sales in North America were off by 2.2 percent excluding currency exchange for the three months ended April 4. CEO Dave Wentz expects the firm's associate ranks to grow and noted that the number of active North American associates grew slightly, 2.1 percent, over the year-ago quarter to 97,000

You may also be interested in...

Liquid Biopsy Company Delfi Diagnostics Raised $100M For New Class of Early Cancer Detection Test

Delfi Diagnostics will use the new funds to expand its team of cancer researchers and machine-learning experts to validate its novel approach for early cancer detection through multiple prospective clinical trials. 

Biotin And ‘Healthy Hair’: Federal Pre-emption Clips False Advertising Complaint In California

US Ninth Circuit affirms a district court’s summary judgment in favor of Target and manufacturer of Up & Up brand biotin supplement it sells. Indian manufacturer targeted in putative class-action in New York prompted FDA’s 2016 creation of import alert category for Ayurvedic supplements.

Execs On The Move: Medical Microinstruments Gets New CEO; Changes At iRhythm; Aethlon Makes A Promotion

Corindus Vascular Robotics CEO made a lateral move to Medical Microinstruments; iRhythm hires a new CEO, while the former CEO stays on as a director; Aethlon promotes a director to chief business officer; and more.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts